Immatics (IMTX) Profit After Tax (2019 - 2025)
Immatics (IMTX) reported Profit After Tax of -$41.6 million for Q4 2025, down 195.42% on a YoY basis from $43.6 million in Q4 2024, and up 29.68% sequentially from -$59.1 million in Q3 2025.
Immatics (IMTX) Profit After Tax (2019 - 2025) Analysis & Trends
Immatics (IMTX) has 7 years of Profit After Tax data on file, last reported at -$41.6 million in Q4 2025.
- For the quarter ending Q4 2025, Profit After Tax fell 195.42% year-over-year to -$41.6 million; the trailing twelve-month figure through Dec 2025 stood at -$222.2 million (down 1496.09% YoY), and the FY2025 full-year result was -$221.9 million, down 1447.51% from the prior year.
- Profit After Tax grew to -$41.6 million in Q4 2025, from -$59.1 million in the prior quarter.
- In the past five years, Profit After Tax ranged from a high of $43.6 million in Q4 2024 to a low of -$79.6 million in Q2 2025.
- A 5-year average of -$16.6 million and a median of -$19.7 million in 2024 frame the typical range for Profit After Tax.
- Peak annual rise in Profit After Tax reached 314.84% in 2023, while the deepest fall reached 1388698.56% in 2023.
- Tracing IMTX's Profit After Tax over 5 years: stood at -$19.2 million in 2021, then surged by 111.78% to $2.3 million in 2022, then sank by 1232.27% to -$25.6 million in 2023, then soared by 270.05% to $43.6 million in 2024, then tumbled by 195.42% to -$41.6 million in 2025.
- Business Quant data shows IMTX's Profit After Tax at -$41.6 million in Q4 2025, -$59.1 million in Q3 2025, and -$79.6 million in Q2 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -36.84 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 227.36 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1.03 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -65.60 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | -26.94 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 362.00 Mn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -453.82 Mn |
| 10 | Immatics | 1.14 Bn | 1.14 Bn | - | -41.55 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -41.55 Mn |
| Sep 30, 2025 | -59.09 Mn |
| Jun 30, 2025 | -79.63 Mn |
| Mar 31, 2025 | -41.92 Mn |
| Dec 31, 2024 | 43.55 Mn |
| Sep 30, 2024 | -5.83 Mn |
| Jun 30, 2024 | -19.38 Mn |
| Mar 31, 2024 | -2.43 Mn |
| Dec 31, 2023 | -25.61 Mn |
| Sep 30, 2023 | -28.84 Mn |
| Jun 30, 2023 | 26.80 Mn |
| Mar 31, 2023 | -21.20 Mn |
| Dec 31, 2022 | 2.26 Mn |
| Sep 30, 2022 | -19.98 Mn |
| Jun 30, 2022 | -12.47 Mn |
| Mar 31, 2022 | 1,526.38 |
| Dec 31, 2021 | -19.20 Mn |
| Sep 30, 2021 | -32.08 Mn |
| Jun 30, 2021 | 31.95 Mn |
| Mar 31, 2021 | -27.52 Mn |